Greenwich LifeSciences Inc. Common Stock (GLSI)

About GLSI

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Website

greenwichlifesciences.com

Fundamentals

Market cap

$209.02M

P/E (trailing)

—

P/E (forward)

—

EPS (trailing)

$-1.56

Dividend yield

—

Beta

1.53

Avg. volume

—

Greenwich LifeSciences Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• GLSI

  Greenwich LifeSciences Inc. Common Stock

  $15.67

  ▼ 16.34%
  Market cap $209.02MP/E —
  $7.78$34.1
• MSLE

  Satellos Bioscience Inc. Common Stock

  $8.92

  ▼ 7.23%
  Market cap $209.77MP/E —
  $7.08$18.98
• NERV

  Minerva Neurosciences Inc Common Stock

  $4.85

  ▼ 5.56%
  Market cap $206.85MP/E —
  $1.93$12.46
• NBP

  NovaBridge Biosciences American Depositary Shares

  $1.85

  ▼ 2.38%
  Market cap $196.15MP/E —
  $1.46$6.79
• SIGA

  SIGA Technologies Inc. Common Stock

  $3.07

  ▲ 0.33%
  Market cap $223.78MP/E —
  $2.83$9.45
• TNXP

  Tonix Pharmaceuticals Holding Corp. Common Stock

  $13.59

  ▲ 0.18%
  Market cap $185.71MP/E —
  $9.4$33.22
• ACIU

  AC Immune SA Common Stock

  $2.67

  ▼ 1.48%
  Market cap $236.11MP/E —
  $2.03$4

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held

1.60M

Total value held

$38.34M

Institutional holders

60